Day: May 19, 2025

Form 8.3 – Craneware plc – Octopus Investments

Written by Customer Service on May 19, 2025. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: OCTOPUS INVESTMENTS LTD(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Craneware plc(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken:...

Viomi Unveils Next-Generation Mineral Water Purifiers, Leading Household Drinking Water into the Era of Pure Mineral Water

Written by Customer Service on May 19, 2025. Posted in Public Companies.

GUANGZHOU, China, May 19, 2025 (GLOBE NEWSWIRE) — Viomi Technology Co., Ltd (“Viomi” or the “Company”) (NASDAQ: VIOT), a leading technology company for home water solutions in China, today announced the official launch of its groundbreaking Kunlun 4 Pro Alkaline Mineral Water Purifier. Unveiled at a special product event held on May 16th, this next-generation water purifier harnesses AI technology to replicate the natural mineral water formation process, aiming to elevate household drinking water from the era of “pure water” to the new era of “pure mineral water,” and offering a solution for families seeking mineral-rich drinking water at home.To better meet the growing consumer demand for mineral-rich water at home, Viomi established the Kunlun Mineral Technology Research Center, investing over RMB100 million in the past three...

MEDIROM Healthcare Technologies Inc. to Host Webcast on May 21, 2025 at 8:30 AM ET to Discuss 2024 Financial Results

Written by Customer Service on May 19, 2025. Posted in Public Companies.

TOKYO, May 19, 2025 (GLOBE NEWSWIRE) — MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a holistic healthcare company based in Japan (the “Company” or “MEDIROM”) today announced that it will host a webcast to review the Company’s financial results for the fiscal year ended December 31, 2024, on Wednesday, May 21, 2025 at 8:30 am Eastern Time. The Company will issue a press release discussing those results after the market close on Tuesday, May 20th, 2025. In addition, on April 29, 2025, the Company filed its most recent annual report on Form 20-F, which annual report covers the Company’s financial results for the 2024 fiscal year and is available on the Securities and Exchange Commission website at www.sec.gov. To access the webcast, please go to the following URL five to ten minutes prior to its start: https://event.choruscall.com/mediaframe/webcast.html?webcastid=9rHZ3uFf To...

Form 8.3 – [CRANEWARE PLC – 16 05 2025] – (CGAML)

Written by Customer Service on May 19, 2025. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree CRANEWARE PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position...

Form 8.3 – [CRANEWARE PLC – 16 05 2025] – (CGWL)

Written by Customer Service on May 19, 2025. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree CRANEWARE PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position held/dealing...

Form 8.3 – [GLOBALDATA PLC – 16 05 2025] – (CGWL)

Written by Customer Service on May 19, 2025. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree GLOBALDATA PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position held/dealing...

Prime Medicine Announces Strategic Restructuring to Focus on Opportunities in Large Genetic Liver Diseases, Cystic Fibrosis, and Partnered Programs Alongside CEO Leadership Transition

Written by Customer Service on May 19, 2025. Posted in Public Companies.

— Initial positive data from Phase 1/2 clinical trial of PM359 in CGD provide clinical proof-of-concept for Prime Editing as a transformative gene editing technology — — On-track to file IND and/or CTA for Wilson’s Disease and AATD programs in 1H 2026 and mid-2026, respectively; initial clinical data for both expected in 2027 — — Allan Reine, M.D., CFO, to succeed Keith Gottesdiener, M.D., as CEO; Jeff Marrazzo, member of the Board of Directors, named Executive Chair — — Implementing cost cutting measures to significantly reduce cash needs in advance of key data inflection points — CAMBRIDGE, Mass., May 19, 2025 (GLOBE NEWSWIRE) — Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies,...

Plug Power CFO, Paul Middleton, Underscores Confidence in Financial Strength and Strategic Growth with Share Purchase

Written by Customer Service on May 19, 2025. Posted in Public Companies.

SLINGERLANDS, N.Y., May 19, 2025 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive solutions for the hydrogen economy, today announced that its Chief Financial Officer, Paul Middleton, has purchased Plug’s common stock in an open market transaction, underscoring his conviction in Plug’s current strategy and future potential to dominate the hydrogen economy at scale. On May 16, 2025, Middleton acquired 350,000 shares at an average price of $0.7154 per share, for a total investment of approximately $250,000. “I remain confident in Plug’s long-term strategy and the opportunities ahead as we continue to execute our vision in the hydrogen economy,” said Middleton. “This purchase reflects my belief in the company’s financial strength and growth potential.” This announcement follows Plug’s Q1 2025 earnings...

Global Ship Lease Reports Results for the First Quarter of 2025

Written by Customer Service on May 19, 2025. Posted in Earnings Releases And Operating Results.

Forward contract cover locked in for 93% of 2025 days and 75% of 2026 days Annualized dividend increased to $2.10 per Class A Common Share ATHENS, Greece, May 19, 2025 (GLOBE NEWSWIRE) — Global Ship Lease, Inc. (NYSE: GSL) (the “Company”, “Global Ship Lease” or “GSL”), an owner of containerships, announced today its unaudited results for the three months ended March 31, 2025. First Quarter of 2025 Highlights and Other Recent Developments1Q 2025 operating revenue of $191.0 million; up 6.3% on 1Q 2024. 1Q 2025 net income available to common shareholders of $121.0 million, or $3.40 Earnings per Share (EPS); up 35.2% on 1Q 2024. 1Q 2025 normalized net income3 of $94.3 million, or $2.65 normalized EPS³ up 5.8% on 1Q 2024. 1Q 2025 Adjusted EBITDA3 of $132.3 million; up 5.5% on 1Q 2024. Added $352 million of contracted revenues during...

Oxford Lane Capital Corp. Announces Net Asset Value and Selected Financial Results for the Fourth Fiscal Quarter and Provides April Net Asset Value Update

Written by Customer Service on May 19, 2025. Posted in Earnings Releases And Operating Results.

GREENWICH, Conn., May 19, 2025 (GLOBE NEWSWIRE) — Oxford Lane Capital Corp. (NasdaqGS: OXLC) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO) (NasdaqGS: OXLCZ) (NasdaqGS: OXLCN) (NasdaqGS: OXLCI) (NasdaqGS: OXLCG) (“Oxford Lane,” the “Company,” “we,” “us” or “our”) announced today the following financial results and related information:As previously announced, on March 26, 2025, our Board of Directors declared the following distributions on our common stock:Month Ending Record Date Payment Date Amount Per ShareJuly 31, 2025 July 17, 2025 July 31, 2025 $0.09August 31, 2025 August 15, 2025 August 29, 2025 $0.09September 30, 2025 September 16, 2025 September 30, 2025 $0.09 Net asset value (“NAV”) per share as of March 31, 2025 stood at $4.32, compared with a NAV per share on December 31, 2024 of $4.82.In...

Day: May 19, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals